Megi Health

What Megi Health does

Megi Health is a London-headquartered digital health company (legal entity MEGI HEALTH UK LTD) that operates an AI-powered platform focused on women's cardiovascular health, with initial use case centered on predicting preeclampsia risk during pregnancy and supporting postpartum and lifelong heart health monitoring. The company was founded in 2023 as a spin-off from a specialized cardiovascular disease clinic (Magdalena Clinic), combining clinical cardiology expertise with data science to build proprietary predictive algorithms trained on longitudinal datasets from pregnant women. Its product portfolio includes a consumer-facing mobile app with an AI-powered WhatsApp virtual assistant (built on Taskbase and OpenAI), blood pressure and vitals tracking, and AI-driven risk reports; organization-facing modules for healthcare providers, health plans, employers, and community birth centers/FQHCs; and a Doula Ambassador and certification program for community-led distribution.

The business model is subscription-based across both B2B and B2C surfaces, with a hybrid product-led growth and enterprise sales motion: the consumer app serves pregnant women directly while the company pursues B2B contracts through demo-driven outreach to providers, plans, employers, and community birth centers. Go-to-market is supported by a multi-channel mix including LinkedIn, content marketing, partner referrals from institutional allies (King's College London, Guy's and St Thomas' NHS Foundation Trust, March of Dimes, American Health Association, EIT Health), and the Doula Ambassador community channel. The company maintains offices in London (HQ), Chicago, and Zagreb, with localized compliance frameworks for the UK, US, Croatia, and Kenya, and holds a substantial regulatory stack (CE Mark, ISO 13485, NHS DTAC, DCB 0129, Cyber Essentials, GDPR) that enables sales into NHS and EU health systems. Founded by Nina Sesto (CEO), Megi remains a privately held, early-stage venture with 11–50 employees, no disclosed revenue, and undisclosed funding amounts.

Name

Megi Health

Legal name

MEGI HEALTH UK LTD

Website

https://megi.ai

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

11–50 employees

Short description

Megi Health is a UK-based digital health company that uses proprietary AI and longitudinal clinical data to predict preeclampsia risk during pregnancy and support postpartum and lifelong cardiovascular monitoring for women, selling to providers, health plans, employers, FQHCs, and pregnant consumers.

Ownership category

akta.pro rank

Product category

Digital Health / Maternal Health Software

SIC

Electromedical & Electrotherapeutic Apparatus (3845)

akta.pro primary industry

Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring) (HLALAHAC)

akta.pro secondary industries

Maternal & Neonatal Remote Monitoring Platforms (HLACAFAC), Maternal, Neonatal & Pediatric Remote Monitoring (HLACAPAG)

Keywords

• Digital health platform
• Maternal health monitoring
• Preeclampsia risk prediction
• Cardiovascular health software
• Pregnancy care technology

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Healthcare Organization Subscriptions: Megi appears to offer platform access to healthcare organizations including providers, health plans, employers, and community birth centers/FQHCs, likely through subscription-based enterprise contracts with features like real-time insights and clinical decision support.
2. Consumer Mobile App: Direct-to-consumer mobile application for pregnant women providing personalized guidance, blood pressure monitoring, and health management, potentially through freemium or subscription model.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

Megi Health provides an AI-powered, clinically-validated digital health platform for women's cardiovascular health that begins with pregnancy and extends to lifelong heart wellness. The platform predicts preeclampsia risk before clinical symptoms appear via proprietary AI models trained on longitudinal clinical data, monitors postpartum cardiovascular risk, and supports blood pressure tracking through a consumer mobile app and an AI-powered virtual assistant. Separate enterprise modules are offered to healthcare providers, community birth centers/FQHCs, health plans, and employers for clinical decision support and preventive maternal care.

Product overview

Megi Health offers a unified digital health platform centered on the Megi Platform, which integrates an AI-powered virtual assistant accessible via WhatsApp. The platform is designed for women's cardiovascular health spanning from pregnancy through lifelong care. Organization-specific modules extend the core platform: Megi for Healthcare Providers, Megi for Community Birth Centers & FQHCs, and Megi for Health Plans, each providing tailored clinical decision support, monitoring, and preventive care capabilities. The portfolio also includes supporting programs like Doula Certification and the Megi Doula Ambassadors initiative.

Differentiator

Problem solved

Functional benefit

Products and services

• Megi Platform
• Megi for Healthcare Providers
• Megi for Community Birth Centers & FQHCs
• Megi for Health Plans

Quantifiable outcome

• 85% of pregnant women in the U.S. qualify for low-dose aspirin to reduce preeclampsia risk
• +2 more outcomes

Segments5 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability3 records

Feature5 records

Partnerships

13 partnerships are on record, tiered core and minor.

• King's College LondoncoreStrategic or Co-development PartnerAcademic partnership with King's College London for research and development of cardiovascular health solutions. Megi is a spin-off from cardiovascular disease expertise combined with advanced data science from this academic collaboration.
• March of DimescoreStrategic or Co-development PartnerPartnership with March of Dimes, a leading nonprofit organization fighting for the health of all moms and babies, to advance women's heart health and pregnancy outcomes.
• Guy's and St Thomas' NHS Foundation TrustcoreStrategic or Co-development PartnerPartnership with Guy's and St Thomas' NHS Foundation Trust, one of the UK's leading NHS Foundation Trusts providing clinical services and research in cardiovascular health.
• American Health AssociationcoreStrategic or Co-development PartnerPartnership with American Health Association to advance cardiovascular health initiatives for women, particularly around pregnancy-related complications.
• Action on Pre-eclampsiacoreStrategic or Co-development PartnerPartnership with Action on Pre-eclampsia, a UK-based charity dedicated to improving outcomes for women with preeclampsia through awareness, education, and research.
• EIT HealthcoreStrategic or Co-development PartnerPartnership with EIT Health, a European knowledge and innovation community working to advance healthy living and create economic growth in health innovation.
• Magdalena Clinic for Cardiovascular MedicinecoreStrategic or Co-development PartnerPartnership with Magdalena Clinic for Cardiovascular Medicine for clinical expertise and data in cardiovascular health, leveraging their specialized cardiovascular disease clinic foundation.
• ABHI US AcceleratorminorGTM or Marketing PartnerParticipation in ABHI US Accelerator program supporting UK health technology companies in accessing the US market through mentorship, networking, and market entry support.
• UK Trade & InvestmentminorGTM or Marketing PartnerTrade and investment support from UK government body to facilitate international expansion and market access for UK health technology companies.
• Digital Health LondonminorGTM or Marketing PartnerPartnership with Digital Health London accelerator program supporting digital health innovation in London through networking, education, and market development.
• TaskbasecoreTechnology or IntegrationTechnology partner powering Megi's AI chat feature. Taskbase receives and stores chat messages to maintain conversation history and provide contextual responses. Taskbase's privacy policy governs data handling.
• OpenAIcoreTechnology or IntegrationAI technology partner providing API access for generating AI-powered responses in Megi's chat feature. Chat messages are transmitted via OpenAI API for real-time response generation. OpenAI does not use data for model training.
• InfobipcoreTechnology or IntegrationThird-party API provider used for communication services. Megi utilizes Infobip APIs as part of its communication infrastructure.

Scale indicators3 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• Wildflower Health: Women's health platform delivering digital care navigation, benefits management, and maternal health programs to health plans and employers—comparable B2B2C model targeting the same buyer segments.
• Mahmee: Maternal health platform providing in-person and virtual care coordination for pregnant and postpartum individuals, with strong focus on health plan partnerships and underserved populations—overlapping Megi's FQHC and payer GTM.
• Bloomlife: Pregnancy health monitoring company combining wearable devices with AI-driven analytics for maternal and fetal health. Directly comparable to Megi's remote monitoring and predictive analytics approach.
• Babyscripts: Direct competitor offering a maternal health digital platform with blood pressure monitoring, remote patient monitoring, and risk stratification for pregnancy complications. Operates in the same payer-provider-employer channel structure as Megi.
• Pomelo Care: Virtual maternity care platform combining data analytics with 24/7 clinical support for high-risk pregnancies. Directly competes for health plan and employer maternal care contracts.

Others

• Progyny: Leading fertility benefits management company serving employer and health plan buyers. Adjacent in women's reproductive health but focused on preconception/fertility rather than pregnancy monitoring—represents ecosystem partner or potential M&A adjacency.

Broad incumbents

• Maven Clinic: Large, well-funded virtual care platform spanning fertility, pregnancy, postpartum, and family health. Serves the same employer and payer buyer segments as Megi but with a much broader women's and family health portfolio.
• Ovia Health (Labcorp): Digital women's health platform now owned by Labcorp, offering pregnancy tracking, fertility, and parenting support through employer and health plan benefits. Significant incumbent with established enterprise relationships.
• Philips (Maternal Health/RPM): Global medical device incumbent with remote patient monitoring and connected maternal care solutions. Represents a scaled competitor with established hospital and health system procurement relationships.

Emerging players

• Cayaba Care: Emerging maternal health company focused on community-based care for underserved pregnant populations, with strong payer and FQHC alignment—directly overlapping Megi's value-based care and health equity positioning.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/megi-ai

Compliance7 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries1 record

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Megi Health